FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from ...

Alexander is a practicing internist and drug safety expert at the Johns Hopkins Bloomberg School of Public Health. Americans trust the Food and Drug Administration to make life-and-death decisions in ...

Pitts, a former FDA associate commissioner, was the agency’s senior official in charge of advisory committees. During my time at the Food and Drug Administration, I was the senior official in charge ...